Mar 10, 2025 · Sublocade extended-release injection belongs in a class of medications called opiate partial agonists. Buprenorphine works to prevent withdrawal symptoms when someone stops taking …

Mar 5, 2025 · Sublocade Patient Tips Medically reviewed by Carmen Pope, BPharm. Last updated on March 5, 2025. How it works Upsides Downsides Bottom Line Tips Response/effectiveness …

Mar 8, 2025 · Sublocade is administered as an injection just under the skin (subcutaneous) of your stomach (abdomen), thigh, buttock, or back of the upper arm. After the first two injections, you will …

Sep 16, 2025 · Sublocade package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Mar 5, 2025 · Sublocade is administered as an injection just under the skin (subcutaneous) of your stomach (abdomen), thigh, buttock, or back of the upper arm. After the first two injections, you will …

Mar 31, 2025 · What is Sublocade? Sublocade is used for treatment of moderate to severe opioid use disorder, to reduce cravings for opioids. It needs to be taken together with counseling and …

Sep 8, 2025 · Detailed dosage guidelines and administration information for Sublocade (buprenorphine). Includes dose adjustments, warnings and precautions.

Apr 9, 2025 · Learn about the side effects of Sublocade (buprenorphine), from common to rare, for consumers and healthcare professionals.

Aug 18, 2024 · Sublocade: an extended-release subcutaneous buprenorphine injection (depot formulation) given once a month for the treatment of opioid use disorder. This product does not …

Mar 5, 2025 · Sublocade is an injection that is given once a month. This means a single injection will last at least a month (28 to 30 days). The package insert also states the following: A minimum of 26 days …